glp 1 and fertility Can GLP-1 Medications Improve Fertility? Is Ozempic Safe If You Are TTC? Impact of GLP-1 Receptor Agonists

Dual- and multi-receptor agonists may be a novel drug class to treat obesity and type 2 diabetes mellitus with high efficacy.

Ensuring equitable access and strengthening health systems will be essential to prevent widening health disparities.AgendaCo-chairsDr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMAModeratorDr Gaya Manori Gamhewage, Director, Department of Communication, WHOWelcomingDr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMAPresentation:WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adultsDr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr

CoQ10 Brain Protection & Healthy Longevity Support

Between 2025 and 2030, the global pharmaceutical industry faces a Loss of Exclusivity (LOE) wave that puts an estimated $200 billion to $400 billion in branded drug revenue at direct risk.

Glucagon-like peptide receptor agonists (GLP-1 RAs) now available to promote weight lossWegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)could potentially make much needed gains against the obesity epidemic

Choose online or in-person to master GLP-1s, earn CMEs, and grow your practice.